- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer.Prostate CancerMay 12, 2021
-
First experimental evaluation of multi-target multileaf collimator tracking during volumetric modulated arc therapy for locally advanced prostate cancer.Prostate CancerMay 12, 2021
-
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.Prostate CancerMay 12, 2021
-
Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.Prostate CancerMay 12, 2021
-
Perioperative and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center.Prostate CancerMay 11, 2021
-
Prostate Cancer Targeted X-ray Fluorescence Imaging via Gold Nanoparticles Functionalized with Prostate-Specific Membrane Antigen (PSMA).Prostate CancerMay 11, 2021
-
Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: results from a phase iii trial.Prostate CancerMay 11, 2021
-
Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population.Prostate CancerMay 11, 2021
-
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.Prostate CancerMay 10, 2021
-
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer.Prostate CancerMay 10, 2021
Beyond the Abstracts
-
Pros-IT CNR: An Italian Prostate Cancer Monitoring Project - Beyond the AbstractProstate CancerMay 12, 2021
-
Evaluation of [68Ga]Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients Using the Digital Biograph Vision - Beyond the AbstractProstate CancerMay 11, 2021
-
Defining Oligometastatic Hormone Sensitive Prostate Cancer and Clinically Significant Outcomes: Implications on Clinical Trials? - Beyond the AbstractProstate CancerMay 6, 2021
-
Molecular Medicine Tumor Board: Whole-Genome Sequencing to Inform on Personalized Medicine for a Man with Advanced Prostate Cancer - Beyond the AbstractProstate CancerMay 3, 2021
-
Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer - Beyond the AbstractProstate CancerApril 29, 2021
-
Patterns of Disease Detection Using [18F]DCFPyL PET/CT Imaging in Patients with Detectable PSA Post Prostatectomy Being Considered for Salvage Radiotherapy: A Prospective Trial - Beyond the AbstractProstate CancerApril 27, 2021
-
Preliminary Development of a Mindfulness-Based Group Therapy to Expand Couples' Sexual Intimacy After Prostate Cancer: A Mixed Methods Approach - Beyond the AbstractProstate CancerApril 26, 2021
-
A 38-Gene Model Comprised of Key TET2-Associated Genes Shows Additive Utility to High-Risk Prostate Cancer Cases in the Prognostication of Biochemical Recurrence - Beyond the AbstractProstate CancerApril 21, 2021
-
Stereotactic Body Radiotherapy and High-Dose Rate Brachytherapy Boost in Combination with Intensity Modulated Radiotherapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis - Beyond the AbstractProstate CancerApril 15, 2021
-
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations – Beyond the AbstractProstate CancerMarch 31, 2021